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Abstract
Objective: Although the Beck Hopelessness Scale is often used with the seriously ill, its factor
structure has been given relatively little consideration in this context.
Methods: The factor structure of this scale was examined in a sample of 406 ambulatory
patients with advanced lung or gastrointestinal cancer, using a sequential exploratory-
confirmatory factor analysis procedure.
Results: A two-factor model was consistent with the data: The first factor reflected a negative
outlook and was labeled ‘negative expectations’; the second factor identified a sense of
resignation and was labeled ‘loss of motivation.’
Conclusions: Implications regarding scoring of the scale in this population are discussed, as
are implications of the two-factor structure for our understanding of hopelessness in individuals
with advanced cancer.
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Introduction
Hopelessness has been defined as a set of cognitive
schemata involving negative expectations concern-
ing oneself and one’s future [1]. It was first
operationalized with the publication of the 20-item
Beck Hopelessness Scale (BHS) [1]. This self-report
scale, which was originally developed and validated
among adult psychiatric patients, quickly became
the most frequently used measure of hopelessness
in psychiatric, healthy, and medical populations.
The development of the BHS considerably
advanced research on the construct of hopeless-
ness [2]. Hopelessness is often considered a mani-
festation of depression [3], but it may also represent
a psychological state that is distinct from depres-
sion. In particular, hopelessness plays a unique and
critical role in the development of suicidal ideation
[4], and when measured by the BHS, has been
shown among psychiatric patients to be a stronger
predictor of suicidality than depression [5].
Recently, the growing debate over legalization of
physician-assisted suicide has prompted research
on suicidality among individuals with advanced
medical illness. This research has consistently
reported a strong association between hopelessness
and suicidal ideation in this population [6]. In
hospitalized palliative-care patients with cancer,
hopelessness, as measured by the BHS, was more
strongly correlated with suicidal ideation than was
depression [7]. Similarly, it was strongly correlated
with the desire for hastened death, while control-
ling for depression and physical distress, in
hospitalized palliative-care patients with advanced
cancer [8] or advanced AIDS [9]. Lastly, hope-
lessness was shown to have a strong association
with refusal of life-saving treatments by medically
ill, elderly patients [10]. Other research has
indicated that hopelessness among individuals with
advanced medical illness is strongly associated with
other clinically important outcomes, such as
demoralization, impaired spiritual well-being, and
poor quality of life [11–13]. Moreover, hopelessness
was found to be predictive of cancer mortality at
the population level [14], and reduced survival time
in cancer patients [15], even after controlling for
the effects of depression and other medical risk
factors.
Although hopelessness is a clinically important
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illness, its underlying meaning in this population
remains poorly understood [16]. In particular,
when individuals with advanced illness endorse a
large number of items on the BHS, it is unclear to
what extent their elevated scores reflect a realistic
appraisal of a ‘hopeless’ medical prognosis or a
psychological state of hopelessness [17]. This is an
important distinction because although the state of
hopelessness is associated with negative psycholo-
gical outcomes in the context of a medical illness
[11], awareness of a terminal prognosis is actually
associated with less distress and lower depression
levels compared with a lack of such awareness [18].
This potential difficulty in the interpretation of
elevated BHS scores is highlighted by Abbey et al.
[19], who examined the utility of BHS items in a
sample of palliative-care patients. They observed
that certain items, such as item 5 (‘I have enough
time to accomplish the things I want to do’), have a
high negative endorsement rate, but a low item-
total correlation. They suggested that these items
may reflect a realistic attitude rather than a
pessimistic cognitive style, a finding with implica-
tions for the dimensionality of the BHS in the
context of advanced illness.
Recently, the dimensionality of the BHS was
investigated by Rosenfeld et al. [17], in a sample of
individuals with advanced AIDS. Their confirma-
tory factor analysis (CFA) supported a three-factor
model. The first factor in this model included nine
items and reflected a positive future orientation
(e.g. item 1: ‘I look forward to the future with hope
and enthusiasm’). The second factor contained six
items and reflected the tendency not to attempt to
change one’s situation (e.g. item 20: ‘There’s no use
in really trying to get anything I want because I
probably won’t get it’). The third factor, which
contained five items, reflected a generally pessimis-
tic outlook on the future (e.g. item 7: ‘My future
seems dark to me’). The authors also examined the
correlations among the three factors of the BHS
and other measures of physical and psychological
distress. However, the statistical significance of
these correlations was not reported and, therefore,
the concurrent validity of the three factors was not
established.
The extent to which Rosenfeld et al.’s [17] three-
factor model can be generalized to other samples of
individuals with an advanced medical illness is
unclear. The authors noted the similarity between
their three-factor model and previous factor
models of the BHS derived from psychiatric
samples (e.g. [1,20–23]) and cautioned that their
factor structure may reflect the influence of
comorbid psychiatric disorders rather than ad-
vanced medical illness. Indeed, over half of their
sample had either a current or previous substance
abuse disorder, thus making it comparable to
psychiatric samples described by others (e.g. [23]).
Hence, an examination of the factor structure of
the BHS in a different population with advanced
medical disease is warranted.
In the present study, we assessed the factor
structure of the BHS among individuals with
advanced cancer who had an expected survival of
6–18 months. The investigation in this study was
limited to individuals with advanced gastrointest-
inal (GI) or lung cancer. Lung and GI cancers are
the two most common fatal cancers worldwide [24].
Both are typically diagnosed at an advanced stage,
in which the illness entails a progressive course,
multiple physical symptoms, and limited survival
[25,26]. Based on the factor analyses of the BHS
that we performed on data from this population,
we make recommendations about how the BHS
should be scored and interpreted, and provide
preliminary evidence for the utility of a two-factor
conceptualization by examining simple relation-
ships between scores based on the factors and
important outcome variables. We also discuss the
implications of the emerging factor structure of the
BHS for our understanding of hopelessness in
individuals with advanced cancer.
Method
Participants
Data were collected as part of a larger study of
psychosocial adjustment in patients with advanced
cancer [27]. This study received approval from the
University Health Network Research Ethics
Board, and all participants provided informed
written consent. Participants were recruited from
consecutive patients attending their outpatient
medical or radiation oncology clinic appointments
with a treating oncologist at Princess Margaret
Hospital (PMH), University Health Network, a
comprehensive cancer center in Toronto, Canada.
Patients were eligible if they had been diagnosed
with Stage IIIA, IIIB or IV lung or Stage IV GI
cancer, were 18 years of age or older, and were able
to speak and read English sufficiently to provide
informed consent and complete questionnaires.
Patients were excluded if they had a diagnosis of
carcinoid or neuroendocrine carcinoma, or if
significant cognitive impairment was documented
on the medical chart or demonstrated by a failure
to meet the predetermined cut-off score of o20 on
the Short Orientation-Memory-Concentration Test
[28], which was administered by a member of the
research staff at the time of recruitment to the
study. Once recruited, patients were briefly inter-
viewed by a member of the research staff to obtain
demographic information, and to rate performance
status based on the Karnofsky criteria [29]. They
were then given a package of self-report ques-
tionnaires to complete in the clinic or at home.
Medical and demographic data were extracted
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from the medical record of each patient and from
the initial brief interview (for a complete descrip-
tion of the study procedure see [27]).
Measures
Participants completed the BHS [1] as part of a
comprehensive package of self-report instruments.
The BHS includes 9 positive and 11 negative true/
false statements about the future. After reverse
scoring of positively worded items, items can be
summed to give a total score ranging from
0 to 20, with a higher score reflecting increased
hopelessness.
Other self-report instruments were included in
the package to assess physical and psychosocial
distress (for a complete description of the mea-
sures, see [27]). Physical symptoms were assessed
using the Memorial Symptom Assessment Scale
(MSAS) [30] and the Brief Pain Inventory
(BPI) [31]. The MSAS [30] is a multidimensional
self-report scale developed to assess the presence,
frequency, severity, and distress associated with
common symptoms of cancer. A 10-item MSAS
Global Distress Index (MSAS-GDI) is considered
to be a measure of overall symptom distress. The
MSAS-GDI is the average of the frequency of four
prevalent psychological symptoms (feeling sad,
worrying, feeling irritable, and feeling nervous)
and the distress associated with six prevalent
physical symptoms (lack of appetite, lack of
energy, pain, feeling drowsy, constipation, dry
mouth). The BPI [31] is a widely used numeric
rating scale of pain intensity (rated from 0 ‘no pain’
to 10 ‘pain as bad as you can imagine’) and pain
interference (rated from 0 ‘does not interfere’ to 10
‘completely interferes’) in the past 24 h.
Psychological distress was assessed using the
Beck Depression Inventory-II (BDI-II) [32] and the
Schedule of Attitudes Toward Hastened Death
(SAHD) [33]. The BDI-II [32] is a 21-item self-
report measure of the intensity of symptoms of
depression and is consistent with the criteria of the
Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition, Text Revision (DSM-IV-
TR) for major depressive disorder. Items (rated
0–3) are summed to give a total score ranging from
0 to 63, with higher scores reflecting more severe
depressive symptoms. The SAHD [33] is a 20-item
self-report true/false measure of the desire for
hastened death that has been validated in cancer
patients in a palliative-care setting. After reverse
scoring of positively worded items, items are
summed to give a total score ranging from 0 to
20, with a higher score reflecting a higher desire for
hastened death.
Finally, physical functioning was rated by a
member of the research staff with patient input,
using the Karnofsky Performance Status (KPS)
scale [29], a widely used observer-rated measure of
the extent to which individuals can carry out
normal activities and self-care, and which has been
used as a predictor of survival [34,35]. Ratings are
made along a continuum ranging from 100 (normal
activities, no complaints, no evidence of disease)
downward in decrements of 10 to 0 (dead).
Data analysis
Because previous research has not provided clear
guidance on the number of factors underlying the
BHS in this population, we investigated the BHS
factor structure using a sequential exploratory-
confirmatory approach (see [36]). The dataset was
randomly divided into two independent sub-
samples, with the first sub-sample used for
exploratory factor analysis (EFA). The factor
model implied by the EFA was then cross-
validated with the second sub-sample using CFA.
Both EFA and CFA were conducted with a
method that is considered to be appropriate for
binary (true/false) items, namely least squares
model estimation from the tetrachoric correlation
matrix (see [37–40]). Cases with missing data were
excluded. Factor analyses were conducted using
Mplus version 3.12 [41].
Both the EFA and CFA were conducted using a
robust-weighted least-squares estimator recom-
mended for factor analyses of binary scales [42].
In the EFA, factors were rotated with an oblique
rotation (Promax) to reflect our expectation
that the underlying factors may be correlated.
Determination of the number of factors to retain in
the final solution was based on a number
of criteria. First, we inspected the scree plot of
eigenvalues. Second, we examined the percent of
total variance explained by each factor solution.
Third, we evaluated the ease of factor interpret-
ability. Fourth, we examined the root-mean-square
error of approximation (RMSEA) fit statistic,
with a value of less than 0.06, indicating good fit
with binary outcomes [43]. For interpretation
of the rotated factor pattern, an item was
considered salient for a factor if the loading was
greater than or equal to 0.40. Cross-loadings
were allowed.
We then conducted a CFA on a second sub-
sample to cross-validate the factor structures
derived from our EFA. Model fit was evaluated
based on five goodness-of-fit indices, including the
Tucker–Lewis Index (TLI), the Comparative Fit
Index (CFI), the RMSEA, and the weighted root-
mean-square residual (WRMR). All are considered
to work well with binary data and to be superior to
the traditional chi-square criterion for model
evaluation, which tends to be inflated when
tetrachoric correlations are used [42]. When used
with binary outcomes, TLI and CFI values of less
than 0.90 indicate lack of fit, values between 0.90
and 0.95 indicate reasonable fit, and values
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between 0.95 and 1.00 indicate good fit; for
WRMR, values of less than 0.95 indicate good
fit [43]. The RMSEA is a particularly useful statistic
for examining model fit (e.g. [44]), with a value of
less than 0.06 indicating good fit with binary
outcomes [43]. Comparison of nested models
(see [45]) was also conducted, which required the
use of a method described by Satorra [46] for chi-
square difference tests (namely, the chi-square
difference test for the Satorra–Bentler scaled chi-
square statistics) because the robust weighted least
squares estimation method elicits a re-scaled chi-
square statistic (see [42]).
Once a final factor structure was obtained,
reliability analyses were performed to determine
the internal consistency (Cronbach’s alpha) of the
obtained factors. Lastly, to provide a preliminary
investigation of the criterion validity of the BHS
factor structure, correlational analyses were con-
ducted to examine the associations among the sum
scores representing the emerging BHS factors and




A total of 1247 consecutive patients who attended
the ambulatory outpatient clinics at PMH between
November 1, 2002 and December 4, 2006 (recruit-
ment in the lung tumor site began in January 2004)
were considered for participation in this study.
Three hundred sixty-one patients were excluded
because they were not able to speak English
sufficiently or because of cognitive impairment.
Of the 886 eligible patients, 531 (60%) consented to
participate in the study. Patients who refused study
participation (N5 355) did not differ from the
participants in terms of gender or primary cancer
site (GI vs lung; these were the only data available
for comparison due to strict guidelines at our
institution regarding privacy and confidentiality of
patient information).
Of the 531 patients who consented to participate,
21 died and 91 withdrew from the study prior to
returning their questionnaires, and 13 had not yet
returned their questionnaires by the time of the
present analyses, leaving a total of 406 participants
with returned questionnaires. The 406 participants
included 234 men (57.6%), and the mean age of
participants was 61.5 years (SD 11.1, range 21–88).
Because recruitment of lung patients began more
than 1 year after recruitment of GI patients had
started, the majority of participants (283; 69.7%) had
GI cancer. However, tests for potential sample bias
indicated that there were no statistically significant
differences on any of the demographic or distress
variables between the GI and lung patients.
The mean BHS total score of participants was
5.3 (SD 4.7, range 0–20), and 100 participants
(25%) reported moderate to severe levels of hope-
lessness, based on a BHS cut-off score of X8
suggested by Beck et al. [5]. Additional sample
characteristics and descriptive values for distress
measures are provided in Table 1.
Table 1. Sample characteristics (N5 406)
Variable domain Variable Description
Demographic information Gender: f/n (%)
Male 234/406 (57.6%)
Female 172/406 (42.4%)
Age (years) mean (sd); range 61.5 (11.1) (21–88)
Marital Status: f/n (%)
Married or common law 290/406 (71.5%)
Separated or divorced 52/406 (13.3%)
Widowed 22/406 (5.4%)
Single 42/406 (10.3%)
Education (beyond high school): f/n (%) 338/406 (83.2%)
Canadian born f/n (%) 256/402 (63.1%)
Mean family income (mean (sd)) (based on postal code) 93 954 (61 502)
Cancer site: f/n (%)
GI 283/406 (69.7%)
Lung 123/406 (30.3%)
Psychometric markers Overall symptom distress mean (sd) (range) 2.1 (0.9) (0–4.6)
Pain intensity (average) mean (sd) (range) 1.5 (1.9) (0–8.5)
Pain interference mean (sd) (range) 3.6 (5.1) (0–20)
Performance status mean (sd) (range) 81.5 (9.4) (40-90)
Depression mean (sd) (range) 10.9 (7.4) (0–51)
Hopelessness mean (sd) (range) 5.3 (4.7) (0–20)
Desire for hastened death mean (sd) (range) 1.7 (2.2) (0–12.9)
Overall symptom distress was assessed using the MSAS-GDI [30]; pain intensity, and pain interference—the BPI [31]; performance status—the KPS [29]; depression—the
BDI-II [32]; hopelessness—the BHS [1]; desire for hastened death—the SAHD [33].
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Factor analyses
Prior to the factor analyses, a listwise deletion
of cases with missing values was conducted,
resulting in the deletion of 65 cases (16%). An
inspection of the frequency of missing data by
individual items did not identify any single item
that contributed to most of the deletions. The
remaining dataset of 341 cases was then randomly
divided into two sub-samples: The first contained
N5 170 cases and provided data for EFA and
the second sub-sample of N5 171 provided data
for CFA.
Exploratory factor analysis
The scree plot suggested that either a one- or two-
factor model would adequately fit the data and
were retained for subsequent inspection. The one-
factor model accounted for 58.26% of the variance
in item scores, with factor loadings for all items
exceeding the 0.40 cut-off. However, the RMSEA
statistic of this model was 0.075, suggesting
mediocre model fit. The two-factor model
accounted for 69.09% of the variance in item
scores and had a RMSEA of 0.03, indicating good
model fit. Both of the factors had good interpret-
ability. The first factor included twelve items with
moderate to high factor loadings (40.40). Items
generally reflected a negative outlook, and there-
fore the factor was labeled ‘negative expectations.’
The second factor included 10 items with moderate
to high factor loadings (40.40). It included items
reflecting a sense of resignation and giving-up. This
factor was named ‘loss of motivation.’ Two
items, item 11 and item 12, cross-loaded on both
factors. The correlation between factors was
moderate (0.57).
Confirmatory factor analysis
A CFA to test the one- and two-factor models
derived from the EFA was conducted with data
from the sub-sample of 171 cases. According to the
RMSEA, the one-factor model had a mediocre fit
to the data, RMSEA5 0.080, TLI5 0.981,
CFI5 0.983, and WRMR5 0.997. The two-factor
model had a better fit to the data, RMSEA5 0.058,
TLI5 0.990, CFI5 0.991, and WRMR5 0.831.
Factor loadings for the two-factor model were all
statistically significant ( po0.05), except those
involving items 11 and 12. These items, which
cross-loaded on both factors in the EFA, had non-
significant loadings on the first factor and sig-
nificant loadings on the second factor. Therefore,
we further constrained the model, removing items
11 and 12 from the first factor. The final model
included 10 items on each factor (see Table 2 for
factor compositions and loadings) and fit the data
well, RMSEA5 0.057, TLI5 0.990, CFI5 0.991,
and WRMR5 0.845. A high inter-factor correla-
tion was obtained (0.85). In addition, a chi-square
difference test revealed that the two-factor model
fitted the data significantly better ( po0.01) than
the one-factor model (which was specified as a two-
factor model with an inter-factor correlation equal
to one). We therefore concluded that the CFA
demonstrated superiority of the two-factor model,
and proceeded to assess the internal consistency
reliability of sub-scales calculated from sum scores
created by summing the items loading on a given
factor. The internal consistency (Cronbach’s alpha)
Table 2. Item composition of the two-factor model
Factor 1– negative expectations Factor loadings
1. I look forward to the future with hope and enthusiasm 0.877
2. I might as well give up because there is nothing I can do about making things better for myself 0.780
3. When things are going badly, I am helped by knowing they cannot stay that way forever 0.725
5. I have enough time to accomplish the things I want to do 0.650
6. In the future, I expect to succeed in what concerns me most 0.888
7. My future seems dark to me 0.947
13. When I look ahead to the future, I expect that I will be happier than I am now 0.788
15. I have great faith in the future 0.962
18. The future seems vague and uncertain to me 0.823
19. I can look forward to more good times than bad times 0.871
Factor 2– loss of motivation Factor loadings
4. I cannot imagine what my life would be like in 10 years 0.325
8. I happen to be particularly lucky, and I expect to get more of the good things in life than the average person 0.534
9. I just can’t get the breaks, and there is no reason I will in the future 0.922
10. My past experiences prepared me well for the future 0.732
11. All I can see ahead of me is unpleasantness rather than pleasantness 0.927
12. I don’t expect to get what I really want 0.855
14. Things just won’t work out the way I want them to 0.902
16. I never get what I want so it’s foolish to want anything 0.883
17. It is very unlikely that I will get any real satisfaction in the future 0.977
20. There is no use in really trying to get anything I want because I probably won’t get it 0.866
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of each factor of the two-factor model was
acceptably high (0.86 for the first factor and 0.83
for the second factor).
Correlational analyses
We used exploratory correlational analyses to
examine the associations among the sub-scales
reflecting the two factors and other criterion
variables (see Table 3). Because of the strong
correlation between the two sub-scales (r5 0.69,
po0.001), partial correlations were calculated
among each sum score and the criterion variables
to adjust for the shared variability between the two
sub-scales. None of the demographic variables was
significantly correlated with either factor. How-
ever, there were differences between the two factors
in terms of their pattern of correlations with the
following measures: Only the first, ‘negative
expectations’ factor, was significantly negatively
correlated with physical performance status, as
measured by the KPS scale [29]. On the other hand,
only the second, ‘loss of motivation’ factor, was
significantly positively correlated with the degree of
symptom distress, as measured by the MSAS [30],
and pain intensity and pain interference in the past
24 h, as measured by the BPI [31]. Depression, as
measured by the BDI-II [32], and the desire for
hastened death, as measured by the SAHD [33],
were significantly correlated with both factors.
Nonetheless, the ‘loss of motivation’ factor had a
higher positive correlation with depression and the
‘negative expectations’ factor had a higher positive
correlation with the desire for hastened death. It is
important to acknowledge, however, that the
statistically significant correlations reported in
Table 3 are relatively weak to moderate.
Discussion
The present study assessed the factor structure of
the BHS in a sample of advanced cancer patients, a
population in which the scale is often used. Our
study supported a two-factor model. The first
factor included 10 items whose endorsement
reflects a general negative outlook (e.g. item 18:
‘The future seems vague and uncertain to me’).
This factor was labeled ‘negative expectations.’ The
second factor also included 10 items and reflects a
sense of resignation and giving-up (e.g. item 20:
‘There is no use in really trying to get anything I
want because I probably won’t get it’). This factor
was named ‘loss of motivation.’ Correlational
analyses between scores on the two factors and
important outcome variables pointed to modest
differences in the criterion validity of the two sub-
scales created from the two factors. However, these
analyses reflect only preliminary exploratory
results, as the primary focus of this study was
establishing the factor structure of the BHS in the
current population.
The distinction made by our factor solution
between the two dimensions of hopelessness may
be particularly important in the context of an
advanced medical illness. In particular, a negative
outlook, as tapped by the ‘negative expectations’
factor, may demonstrate a circumscribed pessimis-
tic assessment of the future, rather than a dysfunc-
tional cognitive scheme, in the context of a poor
medical prognosis. In keeping with this view, the
‘negative expectations’ factor in our study had a
statistically significant negative correlation with
ratings on the KPS scale [29], suggesting that as
functional impairment grows, one’s anticipation of
the future becomes more negative.
The ‘loss of motivation’ factor taps a sense of
helplessness, meaninglessness, and loss of control.
It corresponds to recent published clinical observa-
tions of the demoralization syndrome [11]. This
syndrome is characterized by existential despair, a
breakdown in goal-directed behavior, and help-
lessness, all brought about by the physical and
psychosocial challenges of a medical or mental
illness. The ‘loss of motivation’ factor was unique
in the strength of its positive correlations with
measures of pain intensity and interference, and
with overall symptom distress. This association
may serve to highlight the adverse impact of pain
and physical distress on a sense of personal agency
and control [47]. It is consistent with the concern
that disturbing, though potentially treatable,
symptoms, may lead to demoralization and
helplessness [48].
It is important to note that our correlational
analyses indicated that both factors were signifi-
cantly correlated with variables that are considered
to be closely linked to hopelessness, namely,
depression and the desire for hastened death [3,6].
Although this finding may point to a limitation in
the utility of the two-factor model, it may also be
caused by the multidimensionality of the constructs
of depression and the desire for hastened death in
the context of advanced cancer. Indeed, a recent
study [49] reporting on qualitative interviews with
advanced cancer patients in our sample found that






Overall symptom distress 0.082 0.129
Pain intensity (average in past 24 h) 0.062 0.141
Pain interference 0.057 0.189
Depression 0.201 0.329
Desire for hastened death 0.361 0.165
Performance status 0.108 0.027
po0.05; po0.01; Overall symptom distress (MSAS-GDI); pain intensity and
pain interference (BPI); hopelessness (BHS); depression (BDI-II); desire for
hastened death (SAHD); performance status (KPS).
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high levels of desire for hastened death were related
to two distinct experiences: an expression of
helplessness and despair, and a manifestation of
the recognition that death is imminent and cannot
be resisted. Additional examination of the multiple
facets of the desire for hastened death and their
relationships with the construct of hopelessness is
warranted.
The two-factor solution of the BHS among those
with advanced cancer highlights the need for more
detailed analyses of the construct of hopelessness in
this population, and for potential refinement of the
BHS to disentangle the awareness of a ‘hopeless’
medical prognosis from a psychological state of
helplessness. The dimensionality of the BHS
revealed in the present study calls for caution when
considering the use of shorter versions of the BHS
in the population of individuals with advanced
cancer, such as those suggested by Abbey et al. [19],
Aish and Wasserman [37], or Yip and Cheung [50].
Although these shorter versions of the BHS may be
useful in reducing burden on patients, they may fail
to distinguish between the different facets of
hopelessness.
The two-factor structure that we have identified
in a sample of patients with advanced cancer does
not support Rosenfeld et al.’s [17] findings in a
study, which was the first to examine the dimen-
sionality of the BHS in the context of advanced
disease. Rosenfeld et al.’s [17] study of a sample of
individuals with advanced AIDS generated a three-
factor model. They acknowledge that their model
may not generalize to other medically ill popula-
tions because of the high rate of previous or current
substance abuse disorders in their sample. Indeed,
their factor solution is similar to that reported by
factor analytic studies of the BHS conducted in
psychiatric populations (e.g. [1,20–23], while our
two-factor solution is more similar to that reported
in non-psychiatric populations (e.g. [51–53]).
Individuals with an advanced medical illness are
sometimes viewed as ‘hopeless’ by default [17],
although medical futility and the psychological
state of hopelessness are not necessarily
linked [54]. In that regard, most participants in
our sample had relatively low total scores on the
BHS, with only 25% scoring in the moderate to
severe range. The low mean score of the BHS
reported here is comparable to those reported in
previous studies with hospitalized palliative-care
patients with cancer [8,55].
This study is an important step towards identify-
ing the factor structure of the BHS in a population
consisting exclusively of advanced cancer patients,
a population in which the scale is often used. The
strengths of this study lie in its method: we assessed
the factor structure of the BHS using a sequential
exploratory-confirmatory procedure, with modern
methods (i.e. analysis of tetrachoric correlations)
that account for the binary nature of BHS item
data. The latter is a clear strength, given that
traditional, linear factor analytic methods relying
on product–moment correlations or covariances
(e.g. the principal-components analysis with Pear-
son’s correlations conducted by Beck et al. [1] on
the BHS) are designed for continuous and linearly
related observed variables, and are not considered
appropriate for binary questionnaire items, such as
those from the BHS (e.g. [38,40]). In particular, the
factor analytic method we used is resistant to item
wording effects [40]. Thus, although most of the
first, ‘negative expectations’ factor items are
positively worded and most of the second, ‘loss of
motivation’ factor items are negatively worded, this
two-factor structure is unlikely to be merely an
artifact of item wording.
Several limitations must be considered in the
interpretation of the data. Although the consent
rate of 60% was relatively high for a study in
patients with advanced disease, participants may
have differed in some undetected way from those
who declined participation. In addition, the sample
was drawn from outpatient oncology clinics of two
tumor sites in a comprehensive cancer center.
These patients may differ in important ways from
other patients with other cancer diagnoses or from
patients with advanced disease in the community,
who may be too disabled to attend an outpatient
oncology clinic. Lastly, our sample was character-
ized by relatively high income levels and high
physical performance status, both of which may
impact the level and dimensionality of the hope-
lessness construct.
Further research is needed to determine whether
the two-factor structure emerges in other medical
populations and to better establish its reliability
and validity. In addition, an examination of
whether the factor structure of the BHS remains
stable over time, in the context of a progressive
medical illness, is recommended, as well as an
examination of the construct of hopelessness
among especially vulnerable groups of cancer
patients, including those unable to attend out-
patient clinics and those with linguistic barriers,
which may limit the ability to communicate
verbally with health-care providers. By conceptua-
lizing the BHS according to distinct factors, we
may increase the utility of the BHS as a measure of
distress in the medically ill, and achieve a deeper
understanding of the hopelessness construct and its
role in suicide risk, psychological well-being, and
life expectancy in this population.
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